Mangoceuticals (MGRX) Accounts Payables (2022 - 2026)

Mangoceuticals has disclosed Accounts Payables across 5 years of filings, most recently posting $529800.0 for Q1 2026.

• Accounts Payables for Q1 2026 came in at $529800.0, down 55.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $529800.0 (down 55.03% YoY), and the FY2025 annual result was $416682.0, down 50.25% from the prior year.
• Accounts Payables came in at $529800.0 for Q1 2026 at Mangoceuticals, up from $416682.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $1.2 million in Q1 2025 to a low of $30796.0 in Q1 2023.
• The 5-year median for Accounts Payables is $278723.5 (2023), against an average of $391551.1.
• Across the five-year window, Accounts Payables soared 3266.23% in 2025 and tumbled 55.03% in 2026, its largest moves.
• Mangoceuticals' Accounts Payables stood at $33675.0 in 2022, then soared by 318.01% to $140765.0 in 2023, then jumped by 494.96% to $837501.0 in 2024, then plunged by 50.25% to $416682.0 in 2025, then advanced by 27.15% to $529800.0 in 2026.
• The last three Accounts Payables figures came in at $529800.0 (Q1 2026), $416682.0 (Q4 2025), and $526964.0 (Q3 2025), per Business Quant data.